399 related articles for article (PubMed ID: 26327129)
21. Endoscopic ultrasound guided fine needle aspiration with fluorescence in situ hybridization analysis in 104 patients with pancreatic mass.
Ribeiro A; Peng J; Casas C; Fan YS
J Gastroenterol Hepatol; 2014 Aug; 29(8):1654-8. PubMed ID: 24628622
[TBL] [Abstract][Full Text] [Related]
22. A multistep cytological approach for patients with jaundice and biliary strictures of indeterminate origin.
Boldorini R; Paganotti A; Andorno S; Orlando S; Mercalli F; Orsello M; Ballarè M; Magnani C; Sartori M
J Clin Pathol; 2015 Apr; 68(4):283-7. PubMed ID: 25681513
[TBL] [Abstract][Full Text] [Related]
23. Correlating routine cytology, quantitative nuclear morphometry by digital image analysis, and genetic alterations by fluorescence in situ hybridization to assess the sensitivity of cytology for detecting pancreatobiliary tract malignancy.
Barr Fritcher EG; Kipp BR; Slezak JM; Moreno-Luna LE; Gores GJ; Levy MJ; Roberts LR; Halling KC; Sebo TJ
Am J Clin Pathol; 2007 Aug; 128(2):272-9. PubMed ID: 17638662
[TBL] [Abstract][Full Text] [Related]
24. EUS-FNA with rescue fluorescence in situ hybridization for the diagnosis of pancreatic carcinoma in patients with inconclusive on-site cytopathology results.
Kubiliun N; Ribeiro A; Fan YS; Rocha-Lima CM; Sleeman D; Merchan J; Barkin J; Levi J
Gastrointest Endosc; 2011 Sep; 74(3):541-7. PubMed ID: 21752364
[TBL] [Abstract][Full Text] [Related]
25. An extended fluorescence in situ hybridization approach for the cytogenetic study of cholangiocarcinoma on endoscopic retrograde cholangiopancreatography brushing cytology preparations.
Vasilieva LE; Papadhimitriou SI; Alexopoulou A; Pavlidis D; Kostopoulos I; Georgiakaki M; Xinopoulos D; Romanos A; Dourakis SP
Hum Pathol; 2013 Oct; 44(10):2173-9. PubMed ID: 23845469
[TBL] [Abstract][Full Text] [Related]
26. Value of brush cytology for dominant strictures in primary sclerosing cholangitis.
Ponsioen CY; Vrouenraets SM; van Milligen de Wit AW; Sturm P; Tascilar M; Offerhaus GJ; Prins M; Huibregtse K; Tytgat GN
Endoscopy; 1999 May; 31(4):305-9. PubMed ID: 10376457
[TBL] [Abstract][Full Text] [Related]
27. Fluorescence In Situ Hybridization with the UroVysion Kit for the Detection of Biliary Cancer in Chinese Patients.
Wu X; Zeng X; Yang A; Yao F; Guo T; Wu D; Wu S; Qiu H; Zhou W; Huo Z; Lu X; Qian J
Clin Lab; 2017 Feb; 63(2):407-413. PubMed ID: 28182359
[TBL] [Abstract][Full Text] [Related]
28. Evaluating the Significance of Pancreatobiliary Fluorescence In Situ Hybridization Polysomy on Prognosis in De Novo Cholangiocarcinoma.
Ji H; Barr Fritcher EG; Yin J; Bainter TM; Zemla TJ; Gores GJ; Halling KC; Kipp BR; Roberts LR
Clin Transl Gastroenterol; 2022 Oct; 13(10):e00523. PubMed ID: 36000989
[TBL] [Abstract][Full Text] [Related]
29. Strategies for improving diagnostic accuracy of biliary strictures.
Salomao M; Gonda TA; Margolskee E; Eguia V; Remotti H; Poneros JM; Sethi A; Saqi A
Cancer Cytopathol; 2015 Apr; 123(4):244-52. PubMed ID: 25564796
[TBL] [Abstract][Full Text] [Related]
30. Differential diagnosis of cholangiocarcinoma and IgG4-related sclerosing cholangitis by fluorescence in situ hybridization using transpapillary forceps biopsy specimens.
Kato A; Naitoh I; Miyabe K; Hayashi K; Kondo H; Yoshida M; Kato H; Kuno T; Takahashi S; Joh T
J Hepatobiliary Pancreat Sci; 2018 Mar; 25(3):188-194. PubMed ID: 29532638
[TBL] [Abstract][Full Text] [Related]
31. Chromosomal instability and bladder cancer: the UroVysion(TM) test in the UroScreen study.
Bonberg N; Taeger D; Gawrych K; Johnen G; Banek S; Schwentner C; Sievert KD; Wellhäußer H; Kluckert M; Leng G; Nasterlack M; Stenzl A; Behrens T; Brüning T; Pesch B;
BJU Int; 2013 Aug; 112(4):E372-82. PubMed ID: 23350736
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of fluorescence in situ hybridization as an ancillary tool to urine cytology in diagnosing urothelial carcinoma.
Veeramachaneni R; Nordberg ML; Shi R; Herrera GA; Turbat-Herrera EA
Diagn Cytopathol; 2003 Jun; 28(6):301-7. PubMed ID: 12768634
[TBL] [Abstract][Full Text] [Related]
33. Biliary dysplasia in primary sclerosing cholangitis harbors cytogenetic abnormalities similar to cholangiocarcinoma.
Kerr SE; Barr Fritcher EG; Campion MB; Voss JS; Kipp BR; Halling KC; Lewis JT
Hum Pathol; 2014 Sep; 45(9):1797-804. PubMed ID: 25027853
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis.
Boberg KM; Jebsen P; Clausen OP; Foss A; Aabakken L; Schrumpf E
J Hepatol; 2006 Oct; 45(4):568-74. PubMed ID: 16879890
[TBL] [Abstract][Full Text] [Related]
35. [Endoscopic retrograde cholangiopancreatography-guided brush cytology diagnosis of pancreatobiliary tumors].
Gao L; Man XH; Cai YB; Zheng JM; Zhu MH
Zhonghua Bing Li Xue Za Zhi; 2009 Mar; 38(3):189-93. PubMed ID: 19575856
[TBL] [Abstract][Full Text] [Related]
36. Fluorescence in situ hybridization (FISH) in the diagnosis of bladder and upper tract urothelial carcinoma: the largest single-institution experience to date.
Gomella LG; Mann MJ; Cleary RC; Hubosky SG; Bagley DH; Thumar AB; McCue PA; Lallas CD; Trabulsi EJ
Can J Urol; 2017 Feb; 24(1):8620-8626. PubMed ID: 28263126
[TBL] [Abstract][Full Text] [Related]
37. Endobiliary brush cytology during percutaneous transhepatic cholangiodrainage in patients with obstructive jaundice.
Xing GS; Geng JC; Han XW; Dai JH; Wu CY
Hepatobiliary Pancreat Dis Int; 2005 Feb; 4(1):98-103. PubMed ID: 15730930
[TBL] [Abstract][Full Text] [Related]
38. UroVysion compared with cytology and quantitative cytology in the surveillance of non-muscle-invasive bladder cancer.
Moonen PM; Merkx GF; Peelen P; Karthaus HF; Smeets DF; Witjes JA
Eur Urol; 2007 May; 51(5):1275-80; discussion 1280. PubMed ID: 17084511
[TBL] [Abstract][Full Text] [Related]
39. A comparison of cytology and fluorescence in situ hybridization for the detection of lung cancer in bronchoscopic specimens.
Halling KC; Rickman OB; Kipp BR; Harwood AR; Doerr CH; Jett JR
Chest; 2006 Sep; 130(3):694-701. PubMed ID: 16963665
[TBL] [Abstract][Full Text] [Related]
40. Immunocytochemistry for Claudin-18 and Maspin in biliary brushing cytology increases the accuracy of diagnosing pancreatobiliary malignancies.
Tokumitsu T; Sato Y; Yamashita A; Moriguchi-Goto S; Kondo K; Nanashima A; Asada Y
Cytopathology; 2017 Apr; 28(2):116-121. PubMed ID: 27527114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
